{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T23:25:27Z","timestamp":1786922727971,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08275-8","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:46:08Z","timestamp":1781084768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clozapine-associated systemic inflammatory reaction with adult-onset Still\u2019s disease-like features and marked interleukin-18 elevation in a patient with schizophrenia: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Chiharu","family":"Sugimori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Kawajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Urata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"8275_CR1","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/phar.2887","volume":"43","author":"JG Leung","year":"2023","unstructured":"Leung JG, Zhang L, Markota M, Ellingrod VL, Gerberi DJ, Bishop JR. A systematic review of clozapine-associated inflammation and related monitoring. Pharmacotherapy. 2023;43:1364\u201396. https:\/\/doi.org\/10.1002\/phar.2887.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"8275_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.24869\/psyd.2022.411","volume":"34","author":"J de Leon","year":"2022","unstructured":"de Leon J. Reflections on the complex history of the concept of clozapine-induced inflammation during titration. Psychiatr Danub. 2022;34(3):411\u201321. https:\/\/doi.org\/10.24869\/psyd.2022.411.","journal-title":"Psychiatr Danub"},{"key":"8275_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2019.07.040","volume":"211","author":"H Verdoux","year":"2019","unstructured":"Verdoux H, Quiles C, de Leon J. Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review. Schizophr Res. 2019;211:1\u20139.","journal-title":"Schizophr Res"},{"issue":"2","key":"8275_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1055\/a-1625-6388","volume":"55","author":"J de Leon","year":"2022","unstructured":"de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Sepp\u00e4l\u00e4 N, et al. An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels. Pharmacopsychiatry. 2022;55(2):73\u201386. https:\/\/doi.org\/10.1055\/a-1625-6388.","journal-title":"Pharmacopsychiatry"},{"key":"8275_CR5","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19:424\u201330.","journal-title":"J Rheumatol"},{"issue":"3","key":"8275_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","volume":"81","author":"B Fautrel","year":"2002","unstructured":"Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, et al. Proposal for a new set of classification criteria for adult-onset Still disease. Med (Baltim). 2002;81(3):194\u2013200. https:\/\/doi.org\/10.1097\/00005792-200205000-00003.","journal-title":"Med (Baltim)"},{"issue":"12","key":"8275_CR7","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/ard-2024-225851","volume":"83","author":"B Fautrel","year":"2024","unstructured":"Fautrel B, Mitrovic S, De Matteis A, Bindoli S, Cimaz R, Lehmberg K, et al. EULAR\/PReS recommendations for the diagnosis and management of Still\u2019s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease. Ann Rheum Dis. 2024;83(12):1614\u201327. https:\/\/doi.org\/10.1136\/ard-2024-225851.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8275_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.130575","volume":"41","author":"R Priori","year":"2014","unstructured":"Priori R, Colafrancesco S, Alessandri C, Minniti A, Perricone C, Iaiani G, et al. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still\u2019s disease and sepsis. J Rheumatol. 2014;41(6):1118\u201323.","journal-title":"J Rheumatol"},{"issue":"9","key":"8275_CR9","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1177\/02698811211021587","volume":"35","author":"R de Filippis","year":"2021","unstructured":"de Filippis R, Soldevila-Mat\u00edas P, Guinart D, De Fazio P, Rubio JM, Kane JM, et al. Unravelling cases of clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) in patients reported otherwise: a systematic review. J Psychopharmacol. 2021;35(9):1062\u201373.","journal-title":"J Psychopharmacol"},{"issue":"6","key":"8275_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3109\/00048674.2011.572852","volume":"45","author":"KJ Ronaldson","year":"2011","unstructured":"Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry. 2011;45(6):458\u201365. https:\/\/doi.org\/10.3109\/00048674.2011.572852.","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"8275_CR11","doi-asserted-by":"publisher","first-page":"e228574","DOI":"10.1136\/bcr-2018-228574","volume":"12","author":"A Pathak","year":"2019","unstructured":"Pathak A, Cherry S, Samad S, Aftab A. Successful clozapine rechallenge in a patient with suspected drug induced lupus. BMJ Case Rep. 2019;12(4):e228574. https:\/\/doi.org\/10.1136\/bcr-2018-228574.","journal-title":"BMJ Case Rep"},{"issue":"5","key":"8275_CR12","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1345\/aph.1G552","volume":"40","author":"AF Rami","year":"2006","unstructured":"Rami AF, Barkan D, Mevorach D, Leitersdorf E, Caraco Y. Clozapine-induced systemic lupus erythematosus. Ann Pharmacother. 2006;40(5):983\u20135. https:\/\/doi.org\/10.1345\/aph.1G552.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"8275_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/JCP.0000000000000550","volume":"36","author":"N Buzina","year":"2016","unstructured":"Buzina N, Eterovi\u0107 M. Life-threatening lupus-like syndrome associated with clozapine. J Clin Psychopharmacol. 2016;36(5):532\u20134. https:\/\/doi.org\/10.1097\/JCP.0000000000000550.","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"8275_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/00002826-199708000-00007","volume":"20","author":"G Catalano","year":"1997","unstructured":"Catalano G, Catalano MC, Frankel Wetter RL. Clozapine induced polyserositis. Clin Neuropharmacol. 1997;20(4):352\u20136. https:\/\/doi.org\/10.1097\/00002826-199708000-00007.","journal-title":"Clin Neuropharmacol"},{"issue":"11","key":"8275_CR15","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1176\/appi.ajp.159.11.1947","volume":"159","author":"C Sch\u00f6nfeldt-Lecuona","year":"2002","unstructured":"Sch\u00f6nfeldt-Lecuona C, Connemann BJ. Sweet\u2019s syndrome and polyserositis with clozapine. Am J Psychiatry. 2002;159(11):1947. https:\/\/doi.org\/10.1176\/appi.ajp.159.11.1947.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"8275_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/PRA.0000000000000621","volume":"28","author":"CL Wolfe","year":"2022","unstructured":"Wolfe CL, Hamilton J, Rogahn M, Brooks S, Ahmed I. A case report of clozapine-induced pleural effusion in a 28-year-old Chinese male. J Psychiatr Pract. 2022;28(2):176\u20139. https:\/\/doi.org\/10.1097\/PRA.0000000000000621.","journal-title":"J Psychiatr Pract"},{"issue":"5","key":"8275_CR17","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1192\/bjo.2023.513","volume":"9","author":"A Bunting","year":"2023","unstructured":"Bunting A, Silman D, Karia M, Johnson S. Clozapine and Sweet\u2019s syndrome: case report. BJPsych Open. 2023;9(5):e166. https:\/\/doi.org\/10.1192\/bjo.2023.513.","journal-title":"BJPsych Open"},{"issue":"2","key":"8275_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40263-025-01236-x","volume":"40","author":"Y Kikuchi","year":"2026","unstructured":"Kikuchi Y, Onodera B, Komatsu H, Tomita H. Ethnicity-Based Personalized Clozapine Titration Strategies for Prevention of Clozapine-Induced Inflammation: Recommendations Based on Evidence from the Japanese Population. CNS Drugs. 2026;40(2):181\u201397. https:\/\/doi.org\/10.1007\/s40263-025-01236-x.","journal-title":"CNS Drugs"},{"key":"8275_CR19","doi-asserted-by":"publisher","first-page":"1591568","DOI":"10.3389\/fpsyt.2025.1591568","volume":"16","author":"Y Kikuchi","year":"2025","unstructured":"Kikuchi Y, Tanifuji H, Sakata M, Ikawa K, Kume D, Horikawa N, Ueno S, Onuma Y, Ishihara M, Onodera B, Toraiwa T, Komatsu H, Sato T, Maekawa M, Mano N, Tomita H. Higher clozapine concentration-to-dose ratios at week 1 after initiation are associated with increased risk of clozapine-associated fever in Japanese patients with schizophrenia. Front Psychiatry. 2025;16:1591568. https:\/\/doi.org\/10.3389\/fpsyt.2025.1591568.","journal-title":"Front Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08275-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08275-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08275-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T23:03:02Z","timestamp":1786921382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08275-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8275"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08275-8","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case report was conducted in accordance with the Declaration of Helsinki and its later amendments. The Ethics Committee of Awazu Neuropsychiatric Sanatorium determined that formal ethics approval was not required for this single anonymized case report because written informed consent for publication was obtained from the patient.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of this case report and any accompanying image was obtained from the patient.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"632"}}